Green Cross Pathology And Microbiology Lab Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.72 M
as on 13-12-2024
- Company Age 26 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.46 M
as on 13-12-2024
- Revenue 0.87%
(FY 2022)
- Profit 0.48%
(FY 2022)
- Ebitda -0.11%
(FY 2022)
- Net Worth 8.64%
(FY 2022)
- Total Assets 6.60%
(FY 2022)
About Green Cross Pathology And Microbiology Lab
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.72 M.
The company has closed loans amounting to ₹1.46 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rita Patel, Amarjeetkaur Adarshjitsingh, Narendra Patel, and Four other members serve as directors at the Company.
- CIN/LLPIN
U85110GJ1998PTC033862
- Company No.
033862
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Mar 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Green Cross Pathology And Microbiology Lab?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rita Patel  | Director | 09-Aug-2000 | Current |
| Amarjeetkaur Adarshjitsingh | Director | 15-Mar-2001 | Current |
| Narendra Patel | Director | 15-Mar-2001 | Current |
| Shah Dilip | Director | 09-Aug-2000 | Current |
| Dilip Shah | Director | 15-Mar-2001 | Current |
| Adarshjit Singh | Director | 09-Aug-2000 | Current |
Financial Performance of Green Cross Pathology And Microbiology Lab.
Green Cross Pathology And Microbiology Lab Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.87% increase. The company also saw a slight improvement in profitability, with a 0.48% increase in profit. The company's net worth moved up by a moderate rise of 8.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Green Cross Pathology And Microbiology Lab?
Unlock access to Green Cross Pathology And Microbiology Lab's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Green Cross Genetics Lab Private LimitedActive 10 years 6 monthsAmarjeetkaur Adarshjitsingh, Narendra Patel and 2 more are mutual person
- Green Cross Pathology Laboratory Private LimitedActive 5 years 7 months
Amarjeetkaur Adarshjitsingh and Narendra Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 21 Feb 2008 | ₹1.46 M | Satisfied |
How Many Employees Work at Green Cross Pathology And Microbiology Lab?
Unlock and access historical data on people associated with Green Cross Pathology And Microbiology Lab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Green Cross Pathology And Microbiology Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Green Cross Pathology And Microbiology Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
